Danish shares higher at midday led by Vestas Wind Systems; Moeller
Forbes - Lundbeck was down 1.75 dkr at 161.50, having gained 4.25 yesterday on news that its US partner, Forest Laboratories (nyse: FRX - news - people ), had reported higher-than-expected sales of Lundbeck's Lexapro depression treatment in
Source: www.forbes.com
Online Press Release
PRWeb - Adopt the Depression Treatment Solutions of Satellite Corporation and Give the Gift of Happiness this New Year A depression treatment and stress relief solution formulated from the successful experiences of former depression suffers. Real people who
Source: www.prweb.com
Foolish Forecast: Greener Forest Labs
MSN MoneyCentral - Yet after a rocky start, revenues and earnings have grown to record levels because of Forest Labs' stable of other products, including Lexapro, which succeeded Celexa for depression treatment. Last October, Chairman and CEO Howard Solomon said, "We
Source: news.moneycentral.msn.com
Danish shares close higher, led up by Lundbeck, AP Moeller-Maersk
Forbes - COPENHAGEN (AFX) - Share prices closed higher, led by Lundbeck after its US partner reported higher-than-expected sales of the Danish company's Lexapro depression treatment in the third quarter, and by AP Moeller-Maersk, brokers said. The OMXC20
Source: www.forbes.com
Click here for more information about reactive depression reactive depression
<< Home